← Leaderboards
David Claxton
University Of Texas Md Anderson Can Ctr
$242,547
Attributed
$242,547
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$242,547 · 2
By mechanism
P01$242,547 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Richard E. Champlin$5,988,814
- Xifeng Wu$28,679,533
- Ralph Bernard Arlinghaus$3,580,180
- Kun-Sang Chang$3,987,358
- Elihu Estey$3,196,729
Others in their field
Top investigators on “Histocompatibility Typing”
- Susan E Celniker · University Of Calif-Lawrenc Berkeley Lab$19,381,959
- Martin Friedlander · Scripps Research Institute$17,515,314
- John A Stamatoyannopoulos · Regulome Corporation$16,222,372
- Michael I Nishimura · University Of Chicago$15,397,133
- Bing Ren · Ludwig Institute For Cancer Research$15,115,085
- Greg Westergaard · Alpha Genesis, Inc.$10,419,039
Research focus
Histocompatibility TypingHuman SubjectHuman Therapy EvaluationChronic Myelogenous LeukemiaInterleukin 2Clinical ResearchMixed Tissue /Cell CultureClinical Trial Phase INeoplasm /Cancer ImmunotherapyNeoplasm /Cancer Remission /RegressionPassive ImmunizationPolymerase Chain ReactionScid MouseCombination Cancer TherapyCyclophosphamideCytokineCytotoxic T LymphocyteDendritic CellsFluorescent In Situ HybridizationCell Mediated CytotoxicityCellular ImmunityAutologous TransplantationHelper T LymphocyteApoptosis
Grant awards (5)
AUTOLOGOUS ANTI-CML IMMUNITY$0
P01 · FY2002 · CA
AUTOLOGOUS ANTI-CML IMMUNITY$0
P01 · FY2001 · CA
CORE BINDING FACTOR IN LEUKEMOGENESIS--INV(16) AND T(8;21)$0
P01 · FY2001 · CA
CORE BINDING FACTOR IN LEUKEMOGENESIS--INV(16) AND T(8;21)$163,224
P01 · FY2000 · CA
AUTOLOGOUS ANTI-CML IMMUNITY$79,323
P01 · FY2000 · CA